rabeprazole has been researched along with Colonic Neoplasms in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuoka, H | 1 |
| Ando, K | 1 |
| Swayze, EJ | 1 |
| Unan, EC | 1 |
| Mathew, J | 1 |
| Hu, Q | 1 |
| Tsuda, Y | 1 |
| Nakashima, Y | 1 |
| Saeki, H | 1 |
| Oki, E | 1 |
| Bharti, AK | 1 |
| Mori, M | 1 |
1 other study available for rabeprazole and Colonic Neoplasms
| Article | Year |
|---|---|
CTDSP1 inhibitor rabeprazole regulates DNA-PKcs dependent topoisomerase I degradation and irinotecan drug resistance in colorectal cancer.
Topics: Cell Line, Tumor; Colonic Neoplasms; Colorectal Neoplasms; DNA; DNA Topoisomerases, Type I; DNA-Acti | 2020 |